{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T18:56:31Z","timestamp":1785869791222,"version":"3.56.0"},"reference-count":89,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"12","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,12]]},"abstract":"<jats:p>Preneoplastic and precursor lesions are important to recognize and report, as they can influence clinical management decisions. The International Society of Urological Pathology (ISUP) organized a consensus meeting in Florence, Italy, in September 2024 focused on preneoplastic and precursor lesions of the genitourinary organs. Working group 2 was assigned the topic of bladder and a group of pathologists and clinicians was convened. They developed a 46 question premeeting survey for the ISUP membership assessing flat, papillary, squamous, and glandular entities and clinical issues to determine use of terminology, reporting practices, and areas that needed to be addressed at the consensus meeting. The premeeting survey results showed consistency in the terminology used by pathologists, similarities in reporting practices, and highlighted areas of uncertainty with respect to whether certain entities could be classified as precursors\/preneoplastic. The results enabled the working group to conduct focused literature reviews and to develop a presentation and set of in-meeting polling questions to address the problematic topics from the survey results. Overall, 14\/18 in-meeting polling questions achieved consensus. The surveys and in-person voting demonstrated a strong preference to use existing terminology such as dysplasia, verrucous squamous, and papillary hyperplasia, to grade glandular and squamous dysplasia and to judiciously use immunohistochemistry to classify lesions. Pathologists expressed highly variable opinions with respect to questions about quantification, management recommendations, and inclusion of newer entities as precursors\/preneoplastic lesions.<\/jats:p>","DOI":"10.1097\/pas.0000000000002440","type":"journal-article","created":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T07:00:10Z","timestamp":1751353210000},"page":"e46-e57","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":3,"title":["International Society of Urological Pathology Consensus Meeting 2024"],"prefix":"10.1097","volume":"49","author":[{"given":"Michelle R.","family":"Downes","sequence":"first","affiliation":[{"name":"Division of Anatomic Pathology, Department of Laboratory Medicine and Molecular Diagnostics, Precision Diagnostics and Therapeutics Program, Sunnybrook Health Sciences Centre"},{"name":"Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Lopez-Beltran","sequence":"additional","affiliation":[{"name":"Department of Morphological Sciences, University of Cordoba Medical School, Cordoba, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Contieri","sequence":"additional","affiliation":[{"name":"Department of Urology, Humanitas Clinical and Research Institute IRCCS, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donna E.","family":"Hansel","sequence":"additional","affiliation":[{"name":"Division of Pathology and Laboratory Medicine, University of Texas MD Anderson Cancer Center, Houston, TX"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gladell P.","family":"Paner","sequence":"additional","affiliation":[{"name":"Departments of Pathology and Surgery, Section of Urology, University of Chicago, Chicago, IL"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Shen","sequence":"additional","affiliation":[{"name":"Department of Pathology Genomic Medicine, Houston Methodist Hospital and Weill Cornell Medical College, Houston, TX"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bas W G.","family":"van Rhijn","sequence":"additional","affiliation":[{"name":"Surgical Oncology (Urology), Netherlands Cancer Institute, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hikmat","family":"Al-Ahmadie","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, Genitourinary Pathology Service, Memorial Sloan Kettering Cancer Center, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahul B.","family":"Amin","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, University of Tennessee Health Science Center, Memphis, Tennessee"},{"name":"Department of Urology, USC Keck School of Medicine, Los Angeles, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matteo","family":"Brunelli","sequence":"additional","affiliation":[{"name":"Department of Pathology and Diagnostic, Azienda Ospedaliera Universitaria Integrata Verona, University of Verona, Verona, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Comperat","sequence":"additional","affiliation":[{"name":"Department of Pathology, Tenon Hospital, Sorbonne University, Paris, France"},{"name":"Department of Pathology, Medical University of Vienna, Vienna, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael S.","family":"Cookson","sequence":"additional","affiliation":[{"name":"The University of Oklahoma Health Sciences Center, Oklahoma City, OK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bishoy M.","family":"Faltas","sequence":"additional","affiliation":[{"name":"Weill Cornell Medical College, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles C.","family":"Guo","sequence":"additional","affiliation":[{"name":"Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arndt","family":"Hartmann","sequence":"additional","affiliation":[{"name":"Institute for Pathology, Comprehensive Cancer Center Erlangen-European Metropolitan Area of Nuremberg, Friedrich-Alexander-Universit\u00e4t Erlangen-N\u00fcrnberg, Erlangen University Hospital, Erlangen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashish M.","family":"Kamat","sequence":"additional","affiliation":[{"name":"Department of Urology, University of Texas MD Anderson Cancer Center, Houston, TX"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura S.","family":"Mertens","sequence":"additional","affiliation":[{"name":"Department of Urology, Netherlands Cancer Institute, Amsterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey S.","family":"Ross","sequence":"additional","affiliation":[{"name":"Foundation Medicine, Inc., Cambridge, MA"},{"name":"SUNY Upstate Medical University, Syracuse, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theodorus H.","family":"van der Kwast","sequence":"additional","affiliation":[{"name":"Laboratory Medicine Program, Princess Margaret Cancer Center, University Health Network, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua","family":"Warrick","sequence":"additional","affiliation":[{"name":"Departments of Pathology and Urology, Penn State College of Medicine, Hershey, PA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Glen","family":"Kristiansen","sequence":"additional","affiliation":[{"name":"Institute of Pathology, University Hospital Bonn, Bonn, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Cheng","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, Department of Surgery (Urology), Brown University Warren Alpert Medical School, the Legorreta Cancer Center at Brown University, and Brown University Health, Providence, RI"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria R.","family":"Raspollini","sequence":"additional","affiliation":[{"name":"Histopathology and Molecular Diagnostics, University Hospital Careggi, Florence, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"the Members of ISUP GU Cancer Precursor Consensus Panel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,7,1]]},"reference":[{"key":"R4-20251112","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1097\/00000478-199612000-00007","article-title":"Papillary urothelial hyperplasia. A precursor to papillary neoplasms","volume":"20","author":"Taylor","year":"1996","journal-title":"Am J Surg Pathol"},{"key":"R5-20251112","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/S0002-9440(10)65318-7","article-title":"Frequent genetic alterations in simple urothelial hyperplasias of the bladder in patients with papillary urothelial carcinoma","volume":"154","author":"Hartmann","year":"1999","journal-title":"Am J Pathol"},{"key":"R6-20251112","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1002\/1097-0215(20001120)89:6<514::AID-IJC8>3.0.CO;2-H","article-title":"Papillary urothelial hyperplasia is a clonal precursor to papillary transitional cell bladder cancer","volume":"89","author":"Chow","year":"2000","journal-title":"Int J Cancer"},{"key":"R7-20251112","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1053\/hupa.2002.124031","article-title":"Prognostic significance of atypical papillary urothelial hyperplasia","volume":"33","author":"Swierczynski","year":"2002","journal-title":"Hum Pathol"},{"key":"R8-20251112","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1002\/path.1259","article-title":"Frequent genetic alterations in flat urothelial hyperplasias and concomitant papillary bladder cancer as detected by CGH, LOH, and FISH analyses","volume":"199","author":"Obermann","year":"2003","journal-title":"J Pathol"},{"key":"R9-20251112","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1002\/ijc.21958","article-title":"Chromosome 9 deletions are more frequent than FGFR3 mutations in flat urothelial hyperplasias of the bladder","volume":"119","author":"van Oers","year":"2006","journal-title":"Int J Cancer"},{"key":"R10-20251112","doi-asserted-by":"crossref","first-page":"360","DOI":"10.3109\/00313021003767322","article-title":"Papillary urothelial hyperplasia: relationship to urothelial neoplasms","volume":"42","author":"Readal","year":"2010","journal-title":"Pathology"},{"key":"R11-20251112","doi-asserted-by":"crossref","first-page":"853","DOI":"10.5858\/arpa.2019-0005-OA","article-title":"Urothelial proliferation of unknown malignant potential involving the bladder: histopathologic features and risk of progression in de novo cases and cases with prior neoplasia","volume":"144","author":"Lowenthal","year":"2020","journal-title":"Arch Pathol Lab Med"},{"key":"R12-20251112","doi-asserted-by":"crossref","first-page":"100151","DOI":"10.1016\/j.modpat.2023.100151","article-title":"Frequent telomerase reverse transcriptase promoter and fibroblast growth factor receptor 3 mutations support the precursor nature of papillary urothelial hyperplasia of the urinary bladder","volume":"36","author":"Cheng","year":"2023","journal-title":"Mod Pathol"},{"key":"R13-20251112","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1002\/path.1202","article-title":"Frequent FGFR3 mutations in urothelial papilloma","volume":"198","author":"van Rhijn","year":"2002","journal-title":"J Pathol"},{"key":"R14-20251112","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1097\/01.pas.0000249448.13466.75","article-title":"Low frequency of molecular changes and tumor recurrence in inverted papillomas of the urinary tract","volume":"31","author":"Eiber","year":"2007","journal-title":"Am J Surg Pathol"},{"key":"R15-20251112","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1038\/modpathol.2009.28","article-title":"FGFR3 and TP53 mutation analysis in inverted urothelial papilloma: incidence and etiological considerations","volume":"22","author":"Lott","year":"2009","journal-title":"Mod Pathol"},{"key":"R16-20251112","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1016\/j.humpath.2014.06.003","article-title":"HRAS mutations are frequent in inverted urothelial neoplasms","volume":"45","author":"McDaniel","year":"2014","journal-title":"Hum Pathol"},{"key":"R17-20251112","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1111\/his.12920","article-title":"Telomerase reverse transcriptase (TERT) promoter mutation analysis of benign, malignant and reactive urothelial lesions reveals a subpopulation of inverted papilloma with immortalizing genetic change","volume":"69","author":"Cheng","year":"2016","journal-title":"Histopathol"},{"key":"R18-20251112","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1111\/his.13441","article-title":"Biological significance of TERT promoter mutation in papillary urothelial neoplasm of low malignant potential","volume":"72","author":"Wang","year":"2018","journal-title":"Histopathol"},{"key":"R19-20251112","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1002\/path.5261","article-title":"Genomic landscape of inverted urothelial papilloma and urothelial papilloma of the bladder","volume":"248","author":"Isharwal","year":"2019","journal-title":"J Pathol"},{"key":"R20-20251112","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1097\/PAS.0000000000002171","article-title":"RAS family gene mutations, clinicopathological features, and spread patterns of inverted urothelial papilloma of the bladder","volume":"48","author":"Kitahama","year":"2024","journal-title":"Am J Surg Pathol"},{"key":"R21-20251112","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1038\/s41379-022-01087-7","article-title":"Flat intraurothelial lesions of the urinary bladder-do hyperplasia, dysplasia, and atypia of unknown significance need to exist as diagnostic entities? and how to handle in routine clinical practice","volume":"35","author":"Paner","year":"2022","journal-title":"Mod Pathol"},{"key":"R22-20251112","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1203\/00006450-198807000-00023","article-title":"The effects of prenatal alcohol and marijuana exposure: disturbances in neonatal sleep cycling and arousal","volume":"24","author":"Scher","year":"1988","journal-title":"Pediatr Res"},{"key":"R23-20251112","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.1016\/j.celrep.2019.01.095","article-title":"Whole-organ genomic characterization of mucosal field effects initiating bladder carcinogenesis","volume":"26","author":"Majewski","year":"2019","journal-title":"Cell Rep"},{"key":"R24-20251112","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1002\/(SICI)1098-2264(200004)27:4<392::AID-GCC9>3.0.CO;2-N","article-title":"Genetic modeling of human urinary bladder carcinogenesis","volume":"27","author":"Czerniak","year":"2000","journal-title":"Genes Chromosomes Cancer"},{"key":"R25-20251112","first-page":"809","article-title":"Occurrence of chromosome 9 and p53 alterations in multifocal dysplasia and carcinoma in situ of human urinary bladder","volume":"62","author":"Hartmann","year":"2002","journal-title":"Cancer Res"},{"key":"R26-20251112","doi-asserted-by":"crossref","first-page":"230","DOI":"10.3390\/genes12020230","article-title":"TERT promoter mutation analysis of whole-organ mapping bladder cancers","volume":"12","author":"Weyerer","year":"2021","journal-title":"Genes"},{"key":"R27-20251112","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1002\/(SICI)1097-0142(20000201)88:3<625::AID-CNCR20>3.0.CO;2-A","article-title":"Flat intraepithelial lesions of the urinary bladder","volume":"88","author":"Cheng","year":"2000","journal-title":"Cancer"},{"key":"R28-20251112","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1097\/00000478-199904000-00009","article-title":"Natural history of urothelial dysplasia of the bladder","volume":"23","author":"Cheng","year":"1999","journal-title":"Am J Surg Pathol"},{"key":"R29-20251112","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.urology.2016.11.032","article-title":"Comparison of white light, photodynamic diagnosis, and narrow-band imaging in detection of carcinoma in situ or flat dysplasia at transurethral resection of the bladder: the DaBlaCa-8 study","volume":"102","author":"Drejer","year":"2017","journal-title":"Urology"},{"key":"R30-20251112","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1007\/s10147-014-0748-5","article-title":"Initial experience of combined use of photodynamic diagnosis and narrow band imaging for detection of flat urothelial lesion","volume":"20","author":"Naya","year":"2015","journal-title":"Int J Clin Oncol"},{"key":"R31-20251112","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1186\/1479-5876-8-122","article-title":"Early detection of urothelial premalignant lesions using hexaminolevulinate fluorescence cystoscopy in high risk patients","volume":"8","author":"Blanco","year":"2010","journal-title":"J Transl Med"},{"key":"R32-20251112","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.pathol.2020.10.001","article-title":"Urothelial carcinoma in situ: diagnostic update","volume":"53","author":"McKenney","year":"2021","journal-title":"Pathology"},{"key":"R33-20251112","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1111\/his.13762","article-title":"Precursor lesions of the urinary bladder","volume":"74","author":"McKenney","year":"2019","journal-title":"Histopathology"},{"key":"R34-20251112","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.eururo.2016.02.028","article-title":"The 2016 WHO classification of tumours of the urinary system and male genital organs-part B: prostate and bladder tumours","volume":"70","author":"Humphrey","year":"2016","journal-title":"Eur Urol"},{"key":"R35-20251112","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1309\/AJCPACNUDWEN9GN4","article-title":"Molecular and immunohistologic analyses cannot reliably solve diagnostic variation of flat intraepithelial lesions of the urinary bladder","volume":"134","author":"Murata","year":"2010","journal-title":"Am J Clin Pathol"},{"key":"R36-20251112","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1053\/hupa.2001.27109","article-title":"An objective morphologic parameter to aid in the diagnosis of flat urothelial carcinoma in situ","volume":"32","author":"Milord","year":"2001","journal-title":"Hum Pathol"},{"key":"R37-20251112","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.eururo.2012.09.063","article-title":"ICUD-EAU International Consultation on Bladder Cancer 2012: Pathology","volume":"63","author":"Amin","year":"2013","journal-title":"Eur Urol"},{"key":"R38-20251112","doi-asserted-by":"crossref","first-page":"64","DOI":"10.5858\/arpa.2016-0411-OA","article-title":"CK20 and p53 immunohistochemical staining patterns in urinary bladder specimens with equivocal atypia","volume":"142","author":"Arias-Stella","year":"2018","journal-title":"Arch Pathol Lab Med"},{"key":"R39-20251112","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1097\/00000478-200108000-00013","article-title":"Discriminatory immunohistochemical staining of urothelial carcinoma in situ and non-neoplastic urothelium: an analysis of cytokeratin 20, p53, and CD44 antigens","volume":"25","author":"McKenney","year":"2001","journal-title":"Am J Surg Pathol"},{"key":"R40-20251112","doi-asserted-by":"crossref","first-page":"e20","DOI":"10.1097\/PAS.0000000000000240","article-title":"Best practices recommendations in the application of immunohistochemistry in the bladder lesions: report from the International Society of Urologic Pathology consensus conference","volume":"38","author":"Amin","year":"2014","journal-title":"Am J Surg Pathol"},{"key":"R41-20251112","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1038\/s41379-022-01062-2","article-title":"p53 null phenotype is a \u201cpositive result\u201d in urothelial carcinoma in situ","volume":"35","author":"Sangoi","year":"2022","journal-title":"Mod Pathol"},{"key":"R42-20251112","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1097\/PAS.0000000000000114","article-title":"Utility of a triple antibody cocktail intraurothelial neoplasm-3 (IUN-3-CK20\/CD44s\/p53) and alpha-methylacyl-CoA racemase (AMACR) in the distinction of urothelial carcinoma in situ (CIS) and reactive urothelial atypia","volume":"37","author":"Aron","year":"2013","journal-title":"Am J Surg Pathol"},{"key":"R43-20251112","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.humpath.2020.02.008","article-title":"Immunohistochemical staining patterns of Ki-67 and p53 in florid reactive urothelial atypia and urothelial carcinoma in situ demonstrate significant overlap","volume":"98","author":"Nguyen","year":"2020","journal-title":"Hum Pathol"},{"key":"R44-20251112","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1186\/s13000-019-0871-8","article-title":"Does the addition of AMACR to CK20 help to diagnose challenging cases of urothelial carcinoma in situ?","volume":"14","author":"Alston","year":"2019","journal-title":"Diagn Pathol"},{"key":"R45-20251112","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/s13000-020-00984-2","article-title":"CK20 versus AMACR and p53 immunostains in evaluation of Urothelial Carcinoma in Situ and Reactive Atypia","volume":"15","author":"Neal","year":"2020","journal-title":"Diagn Pathol"},{"key":"R46-20251112","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.humpath.2007.08.005","article-title":"p16ink4 immunoreactivity is a reliable marker for urothelial carcinoma in situ","volume":"39","author":"Yin","year":"2008","journal-title":"Hum Pathol"},{"key":"R47-20251112","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1097\/PAI.0b013e3182351ed3","article-title":"Utility of cytokeratin 5\/6, cytokeratin 20, and p16 in the diagnosis of reactive urothelial atypia and noninvasive component of urothelial neoplasia","volume":"20","author":"Edgecombe","year":"2012","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"R48-20251112","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.eururo.2021.08.010","article-title":"European Association of Urology Guidelines on Non-muscle-invasive Bladder Cancer (Ta, T1, and Carcinoma in Situ)","volume":"81","author":"Babjuk","year":"2022","journal-title":"Eur Urol"},{"key":"R49-20251112","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1093\/ajcp\/aqae167","article-title":"Urothelial carcinoma in situ with \u201cearly papillary formation\u201d vs \u201clateral spread\/shoulder lesion\u201d of prior high-grade noninvasive papillary urothelial carcinoma: A survey of pathologist and urologist interpretations","volume":"163","author":"Sangoi","year":"2025","journal-title":"Am J Clin Pathol"},{"key":"R50-20251112","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1016\/j.urology.2007.11.079","article-title":"Role of cystitis cystica et glandularis and intestinal metaplasia in development of bladder carcinoma","volume":"71","author":"Smith","year":"2008","journal-title":"Urol"},{"key":"R51-20251112","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/S0022-5347(17)62553-9","article-title":"Cystitis glandularis: benign or malignant?","volume":"100","author":"Bell","year":"1968","journal-title":"J Urol"},{"key":"R52-20251112","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/S0022-5347(17)61604-5","article-title":"Cystitis glandularis and adenocarcinoma of the bladder","volume":"105","author":"Susmano","year":"1971","journal-title":"J Urol"},{"key":"R53-20251112","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/S0090-4295(97)00294-X","article-title":"Intestinal metaplasia is not a strong risk factor for bladder cancer: study of 53 cases with long-term follow-up","volume":"50","author":"Corica","year":"1997","journal-title":"Urol"},{"key":"R54-20251112","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1097\/PAS.0000000000001635","article-title":"Mesonephric (Wolffian-derived) adenocarcinoma of the female urethra","volume":"45","author":"Paner","year":"2021","journal-title":"Am J Surg Pathol"},{"key":"R55-20251112","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1111\/j.1365-2559.2010.03651.x","article-title":"Glandular lesions of the urinary bladder:clinical significance and differential diagnosis","volume":"58","author":"Williamson","year":"2011","journal-title":"Histopathol"},{"key":"R56-20251112","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/s41379-020-00655-z","article-title":"Intestinal metaplasia of the urinary tract harbors potentially oncogenic genetic variants","volume":"34","author":"Acosta","year":"2021","journal-title":"Mod Pathol"},{"key":"R57-20251112","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1097\/PAI.0000000000000812","article-title":"Analysis of intestinal metaplasia without dysplasia in the urinary bladder reveal only rare mutations associated with colorectal adenocarcinoma","volume":"28","author":"Amin","year":"2020","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"R58-20251112","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1111\/his.12661","article-title":"Intestinal metaplasia of the bladder with dysplasia: a risk factor for carcinoma?","volume":"67","author":"Gordetsky","year":"2015","journal-title":"Histopathology"},{"key":"R59-20251112","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1016\/S0046-8177(97)90253-7","article-title":"Differentiation of colonic metaplasia from adenocarcinoma of urinary bladder","volume":"28","author":"Jacobs","year":"1997","journal-title":"Hum Pathol"},{"key":"R60-20251112","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1097\/00000478-199612000-00005","article-title":"Florid cystitis glandularis of intestinal type with mucin extravasation: a mimic of adenocarcinoma","volume":"20","author":"Young","year":"1996","journal-title":"Am J Surg Pathol"},{"key":"R61-20251112","doi-asserted-by":"crossref","first-page":"2086","DOI":"10.1002\/1097-0142(19870615)59:12<2086::AID-CNCR2820591220>3.0.CO;2-J","article-title":"The significance of colonic mucosa (intestinal metaplasia) involving the urinary tract","volume":"59","author":"Bullock","year":"1987","journal-title":"Cancer"},{"key":"R62-20251112","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1038\/modpathol.3800670","article-title":"Divergent pathway of intestinal metaplasia and cystitis glandularis of the urinary bladder","volume":"19","author":"Sung","year":"2006","journal-title":"Mod Pathol"},{"key":"R63-20251112","doi-asserted-by":"crossref","first-page":"1892","DOI":"10.1097\/01.ju.0000092740.51330.39","article-title":"The role of beta-catenin signaling in the malignant potential of cystitis glandularis","volume":"170","author":"Bryan","year":"2003","journal-title":"J Urol"},{"key":"R64-20251112","doi-asserted-by":"crossref","first-page":"6232","DOI":"10.1158\/1078-0432.CCR-07-0121","article-title":"Telomere shortening and chromosomal abnormalities in intestinal metaplasia of the urinary bladder","volume":"13","author":"Morton","year":"2007","journal-title":"Clin Cancer Res"},{"key":"R65-20251112","article-title":"The 2023 Dublin International Society of Urological Pathology (ISUP) Consensus Conference Part 2: Best Practice Recommendations on the Pathology of Urinary Bladder Glandular Lesions","author":"Paner","year":"2025","journal-title":"Am J Surg Pathol"},{"key":"R66-20251112","doi-asserted-by":"crossref","first-page":"105734","DOI":"10.1016\/j.humpath.2025.105734","article-title":"Primary adenocarcinoma of the urinary tract and its precursors: Diagnostic criteria and classification","volume":"155","author":"Santa","year":"2025","journal-title":"Hum Pathol"},{"key":"R67-20251112","doi-asserted-by":"crossref","first-page":"107","DOI":"10.3233\/BLC-190257","article-title":"Histologic variants of urothelial carcinoma: morphology, molecular features and clinical implications","volume":"6","author":"Alderson","year":"2020","journal-title":"Bladder Cancer"},{"key":"R68-20251112","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/S0022-5347(17)56384-3","article-title":"The prevalence and significance of Brunn\u2019s nests, cystitis cystica and squamous metaplasia in normal bladders","volume":"122","author":"Wiener","year":"1979","journal-title":"J Urol"},{"key":"R69-20251112","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.5858\/arpa.2021-0320-OA","article-title":"Verrucous squamous hyperplasia of the urinary bladder: a series of 23 cases","volume":"146","author":"Russell","year":"2022","journal-title":"Arch Pathol Lab Med"},{"key":"R70-20251112","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1097\/PAS.0b013e31805c9cd9","article-title":"Squamous cell carcinoma of the bladder: a clinicopathologic analysis of 45 cases","volume":"31","author":"Lagwinski","year":"2007","journal-title":"Am J Surg Pathol"},{"key":"R71-20251112","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1177\/1066896916629783","article-title":"Squamous dysplasia of the urinary bladder: a consecutive cystectomy series","volume":"24","author":"Warrick","year":"2016","journal-title":"Int J Surg Pathol"},{"key":"R72-20251112","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1308\/rcsann.2016.0343","article-title":"Risk factors for development of primary bladder squamous cell carcinoma","volume":"99","author":"Manley","year":"2017","journal-title":"Ann R Coll Surg Engl"},{"key":"R73-20251112","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1128\/CMR.12.1.97","article-title":"Relationship between schistosomiasis and bladder cancer","volume":"12","author":"Mostafa","year":"1999","journal-title":"Clin Microbiol Rev"},{"key":"R74-20251112","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/1756-9966-28-27","article-title":"Tumor markers of bladder cancer: the schistosomal bladder tumors versus non-schistosomal bladder tumors","volume":"28","author":"Abdulamir","year":"2009","journal-title":"J Exp Clin Cancer Res"},{"key":"R75-20251112","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.euros.2021.11.007","article-title":"TERT promoter mutations in keratinizing and nonkeratinizing squamous metaplasia of the urinary tract","volume":"35","author":"Taylor","year":"2022","journal-title":"Eur Urol Open Sci"},{"key":"R76-20251112","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1038\/s41571-024-00904-z","article-title":"Epidemiology of HPV-associated cancers past, present and future: towards prevention and elimination","volume":"21","author":"Malagon","year":"2024","journal-title":"Nat Rev Clin Oncol"},{"key":"R77-20251112","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1097\/01.pas.0000213283.20166.5a","article-title":"Noninvasive squamous lesions in the urinary bladder: a clinicopathologic analysis of 29 cases","volume":"30","author":"Guo","year":"2006","journal-title":"Am J Surg Pathol"},{"key":"R78-20251112","first-page":"11505","article-title":"Bladder squamous cell carcinoma in situ in the background of condyloma acuminatum in a kidney transplant recipient","volume":"30","author":"Yan","year":"2023","journal-title":"Can J Urol"},{"key":"R79-20251112","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1097\/PAS.0000000000001339","article-title":"Condyloma acuminatum of urinary bladder: relation to squamous cell carcinoma","volume":"43","author":"Samarska","year":"2019","journal-title":"Am J Surg Pathol"},{"key":"R80-20251112","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1038\/nature12965","article-title":"Comprehensive molecular characterization of urothelial bladder carcinoma","volume":"507","year":"2014","journal-title":"Nature"},{"key":"R81-20251112","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.cell.2017.09.007","article-title":"Comprehensive molecular characterization of muscle-invasive bladder cancer","volume":"171","author":"Robertson","year":"2017","journal-title":"Cell"},{"key":"R82-20251112","doi-asserted-by":"crossref","first-page":"30","DOI":"10.5858\/arpa.2023-0285-OA","article-title":"Clinicopathologic and molecular characterization of high-risk human papillomavirus-positive carcinomas of the urinary tract","volume":"149","author":"Kayraklioglu","year":"2025","journal-title":"Arch Pathol Lab Med"},{"key":"R83-20251112","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1097\/PAT.0000000000000029","article-title":"Long term outcome of primary urothelial papilloma: a single institution cohort","volume":"46","author":"Al Bashir","year":"2014","journal-title":"Pathol"},{"key":"R84-20251112","doi-asserted-by":"crossref","first-page":"2098","DOI":"10.1002\/(SICI)1097-0142(19991115)86:10<2098::AID-CNCR30>3.0.CO;2-9","article-title":"Urothelial papilloma of the bladder. Clinical and biologic implications","volume":"86","author":"Cheng","year":"1999","journal-title":"Cancer"},{"key":"R85-20251112","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1097\/01.MP.0000073973.74228.1E","article-title":"Urothelial (transitional cell) papilloma of the urinary bladder: a clinicopathologic study of 26 cases","volume":"16","author":"McKenney","year":"2003","journal-title":"Mod Pathol"},{"key":"R86-20251112","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1097\/00000478-200412000-00010","article-title":"Urothelial papilloma of the bladder: a review of 34 de novo cases","volume":"28","author":"Magi-Galluzzi","year":"2004","journal-title":"Am J Surg Pathol"},{"key":"R88-20251112","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.urolonc.2019.10.002","article-title":"Papillary urothelial neoplasm of low malignant potential (PUN-LMP): Still a meaningful histo-pathological grade category for Ta, noninvasive bladder tumors in 2019?","volume":"38","author":"Hentschel","year":"2020","journal-title":"Urol Oncol"},{"key":"R89-20251112","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.eururo.2020.12.033","article-title":"European Association of Urology (EAU) Prognostic Factor Risk Groups for Non-muscle-invasive Bladder Cancer (NMIBC) Incorporating the WHO 2004\/2016 and WHO 1973 Classification Systems for Grade: An Update from the EAU NMIBC Guidelines Panel","volume":"79","author":"Sylvester","year":"2021","journal-title":"Eur Urol"},{"key":"R90-20251112","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1097\/01.ju.0000149163.08521.69","article-title":"A surveillance schedule for G1Ta bladder cancer allowing efficient use of check cystoscopy and safe discharge at 5 years based on a 25-year prospective database","volume":"173","author":"Mariappan","year":"2005","journal-title":"J Urol"},{"key":"R91-20251112","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.euo.2024.08.001","article-title":"Deintensification of treatment for low-grade bladder tumors: a collaborative review by the International Bladder Cancer Group (IBCG)","volume":"8","author":"Contieri","year":"2025","journal-title":"Eur Urol Oncol"},{"key":"R92-20251112","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.euo.2021.05.002","article-title":"Long-term follow-up and factors associated with active surveillance failure for patients with non-muscle-invasive bladder cancer: The Bladder Cancer Italian Active Surveillance (BIAS) experience","volume":"5","author":"Contieri","year":"2022","journal-title":"Eur Urol Oncol"},{"key":"R93-20251112","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.eururo.2022.08.012","article-title":"Outpatient photodynamic diagnosis-guided laser destruction of bladder tumors is as good as conventional inpatient photodynamic diagnosis-guided transurethral tumor resection in patients with recurrent intermediate-risk low-grade ta bladder tumors. a prospective randomized noninferiority clinical trial","volume":"83","author":"Pedersen","year":"2023","journal-title":"Eur Urol"}],"container-title":["American Journal of Surgical Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/PAS.0000000000002440","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T06:00:31Z","timestamp":1762927231000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/PAS.0000000000002440"}},"subtitle":["Working Group 2 Preneoplastic and Precursor Lesions of the Urinary Bladder"],"short-title":[],"issued":{"date-parts":[[2025,7,1]]},"references-count":89,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/pas.0000000000002440","relation":{},"ISSN":["0147-5185","1532-0979"],"issn-type":[{"value":"0147-5185","type":"print"},{"value":"1532-0979","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,1]]}}}